Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Non-Current Debt (2019 - 2025)

Mimedx's Non-Current Debt history spans 9 years, with the latest figure at $16.5 million for Q4 2025.

  • For Q4 2025, Non-Current Debt fell 7.64% year-over-year to $16.5 million; the TTM value through Dec 2025 reached $16.5 million, down 7.64%, while the annual FY2025 figure was $16.5 million, 7.64% down from the prior year.
  • Non-Current Debt for Q4 2025 was $16.5 million at Mimedx, down from $16.8 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $49.0 million in Q3 2023 and bottomed at $16.5 million in Q4 2025.
  • The 5-year median for Non-Current Debt is $48.0 million (2021), against an average of $36.0 million.
  • The largest annual shift saw Non-Current Debt grew 1.01% in 2023 before it tumbled 63.2% in 2024.
  • A 5-year view of Non-Current Debt shows it stood at $48.1 million in 2021, then rose by 0.97% to $48.6 million in 2022, then dropped by 1.02% to $48.1 million in 2023, then tumbled by 62.93% to $17.8 million in 2024, then dropped by 7.64% to $16.5 million in 2025.
  • Per Business Quant, the three most recent readings for MDXG's Non-Current Debt are $16.5 million (Q4 2025), $16.8 million (Q3 2025), and $17.2 million (Q2 2025).